Jie Min

Ef fi cacy and Safety of SH-1028 in Patients With EGFR T790M-Positive NSCLC: A Multicenter, Single-Arm, Open-Label, Phase 2 Trial

Lei Wang, Xueqin Chen, Wei Li, 2022 .

MicroRNA-26a-5p and microRNA-23b-3p up-regulate peroxiredoxin III in acute myeloid leukemia

Y. Liu, Zhaojian Liu, Y. Gong, 2014, Leukemia & lymphoma.

Efficacy and safety of SH-1028 in patients with EGFR T790M positive non-small-cell lung cancer: a multicenter, single-arm, open-label, phase 2 trial.

Xueqin Chen, L. Xing, S. Ren, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinicopathological characteristics, local treatment, and prognostic factors in IE/IIE primary breast lymphoma: a retrospective study of 67 patients

W. Huang, Xin Wang, Bo-wen Liu, 2023, World Journal of Surgical Oncology.

Envonalkib versus crizotinib for treatment-naive ALK-positive non-small cell lung cancer: a randomized, multicenter, open-label, phase III trial

Ying Cheng, Yanqiu Zhao, N. Yang, 2023, Signal transduction and targeted therapy.